Zimmer Biomet Holdings Inc Cash Flow Conversion Efficiency
Zimmer Biomet Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, Zimmer Biomet Holdings Inc (ZBH) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($418.70 Million) by net assets ($12.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zimmer Biomet Holdings Inc (1999–2024)
Cash flow conversion efficiency of Zimmer Biomet Holdings Inc from 1999 to 2024. This chart illustrates how Zimmer Biomet Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zimmer Biomet Holdings Inc (ZBH) stock price for real-time trading data and today's change.
Zimmer Biomet Holdings Inc Cash Flow Conversion Ratio Explained
Zimmer Biomet Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zimmer Biomet Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zimmer Biomet Holdings Inc ranked by their cash flow conversion efficiency. Also see how much is Zimmer Biomet Holdings Inc worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Advantech Co Ltd
TW:2395
|
0.039x |
|
Banco Bradesco S/A ADR
NYSE:BBDO
|
0.432x |
|
Rubrik, Inc.
NYSE:RBRK
|
-0.170x |
|
SK Holdings Co Ltd
KO:034730
|
0.034x |
|
Northern Star Resources Limited
F:NS7
|
0.030x |
|
SS&C Technologies Holdings Inc
NASDAQ:SSNC
|
0.062x |
|
Alliant Energy Corp
NASDAQ:LNT
|
0.050x |
|
KNORR-BREMS. UNSP.ADRS1/4
F:KBXA
|
0.101x |
Annual Cash Flow Conversion Efficiency for Zimmer Biomet Holdings Inc (1999–2024)
The table below shows the annual cash flow conversion efficiency of Zimmer Biomet Holdings Inc from 1999 to 2024. Review Zimmer Biomet Holdings Inc free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $12.48 Billion | $1.50 Billion | 0.120x | -5.11% |
| 2023-12-31 | $12.49 Billion | $1.58 Billion | 0.127x | +18.56% |
| 2022-12-31 | $12.03 Billion | $1.28 Billion | 0.107x | -9.75% |
| 2021-12-31 | $12.67 Billion | $1.50 Billion | 0.118x | +19.88% |
| 2020-12-31 | $12.20 Billion | $1.20 Billion | 0.099x | -22.84% |
| 2019-12-31 | $12.39 Billion | $1.59 Billion | 0.128x | -17.43% |
| 2018-12-31 | $11.28 Billion | $1.75 Billion | 0.155x | +14.93% |
| 2017-12-31 | $11.74 Billion | $1.58 Billion | 0.135x | -20.12% |
| 2016-12-31 | $9.67 Billion | $1.63 Billion | 0.169x | +94.92% |
| 2015-12-31 | $9.81 Billion | $849.80 Million | 0.087x | -46.74% |
| 2014-12-31 | $6.52 Billion | $1.06 Billion | 0.163x | +6.36% |
| 2013-12-31 | $6.30 Billion | $963.10 Million | 0.153x | -22.15% |
| 2012-12-31 | $5.87 Billion | $1.15 Billion | 0.196x | -7.99% |
| 2011-12-31 | $5.51 Billion | $1.18 Billion | 0.213x | +3.20% |
| 2010-12-31 | $5.77 Billion | $1.19 Billion | 0.207x | +4.35% |
| 2009-12-31 | $5.64 Billion | $1.12 Billion | 0.198x | +7.94% |
| 2008-12-31 | $5.65 Billion | $1.04 Billion | 0.184x | -7.68% |
| 2007-12-31 | $5.45 Billion | $1.08 Billion | 0.199x | -5.91% |
| 2006-12-31 | $4.92 Billion | $1.04 Billion | 0.211x | +12.77% |
| 2005-12-31 | $4.69 Billion | $878.20 Million | 0.187x | -14.13% |
| 2004-12-31 | $3.95 Billion | $862.20 Million | 0.218x | +38.99% |
| 2003-12-31 | $3.15 Billion | $494.80 Million | 0.157x | -73.87% |
| 2002-12-31 | $366.30 Million | $220.20 Million | 0.601x | -72.46% |
| 2001-12-31 | $78.70 Million | $171.80 Million | 2.183x | +145.16% |
| 2000-12-31 | $261.00 Million | $232.40 Million | 0.890x | +93.42% |
| 1999-12-31 | $391.00 Million | $180.00 Million | 0.460x | -- |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more